0001108205-23-000045.txt : 20230503 0001108205-23-000045.hdr.sgml : 20230503 20230503160703 ACCESSION NUMBER: 0001108205-23-000045 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20230501 FILED AS OF DATE: 20230503 DATE AS OF CHANGE: 20230503 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Zung Jonathan B. CENTRAL INDEX KEY: 0001837972 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30347 FILM NUMBER: 23883712 MAIL ADDRESS: STREET 1: C/O EVELO BIOSCIENCES, INC. STREET 2: 620 MEMORIAL DRIVE, SUITE 200 CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CURIS INC CENTRAL INDEX KEY: 0001108205 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 043505116 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 128 SPRING STREET STREET 2: BUILDING C, SUITE 500 CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 617-503-6500 MAIL ADDRESS: STREET 1: 128 SPRING STREET STREET 2: BUILDING C, SUITE 500 CITY: LEXINGTON STATE: MA ZIP: 02421 3 1 wf-form3_168314439149706.xml FORM 3 X0206 3 2023-05-01 1 0001108205 CURIS INC CRIS 0001837972 Zung Jonathan B. 128 SPRING STREET BUILDING C - SUITE 500 LEXINGTON MA 02421 0 1 0 0 CDO As of May 1, 2023, the date on which Dr. Zung joined Curis, Inc., Dr. Zung did not own any securities of the Company either directly or indirectly. No securities are beneficially owned. Exhibit Index: 24.1 Power of Attorney /s/ Diantha Duvall, Attorney-in-fact 2023-05-03 EX-24 2 ex-24.htm DIANTHA DUVALL, JAKE BURGESS, JAMES DENTZER, NANCY SOOHOO, WH POA

POWER OF ATTORNEY

The undersigned, as a Section 16 reporting person of Curis, Inc., hereby constitutes and appoints each of James Dentzer, Jake Burgess, Diantha Duvall, Nancy Soohoo and Wilmer Cutler Pickering Hale and Dorr LLP, as outside counsel to the Company, and each of them individually, as his or her true and lawful attorney-in-fact and agent with full power of substitution, for him or her in any and all capacities to:

(1) Execute for and on behalf of the undersigned, in the undersigned's capacity as an officer and/or director of the "Company", Forms 3, 4, and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934 (the "Exchange Act") and the rules thereunder, or any successor laws and regulations promulgated thereunder;

(2) Perform any and all acts for and on behalf of the undersigned which may be necessary or appropriate to complete and execute any such Form 3, 4, or 5, complete and execute any amendment or amendments thereto, and timely file such form with the United States Securities and Exchange Commission and any stock exchange or similar authority; and

(3) Take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact's discretion.

The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned's responsibilities to comply with Section 16 of the Exchange Act.

This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4, and 5 with respect to the undersigned's holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact.

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 1st day of May 2023.


Signature

/s/ Jonathan B. Zung